BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
3826
DELISTED
Adaptimmune Therapeutics
ADAP
| $16.9K | ﹤0.01% |
3,937
| – | – |
|
|
PFSW
3827
DELISTED
PFSweb, Inc.
PFSW
| $16.8K | ﹤0.01% |
3,228
+2,960
| +1,104% | +$17.7K |
|
|
XOMA
3828
DELISTED
Xoma
XOMA
| $16.7K | ﹤0.01% |
1,351
+1,190
| +739% | +$16.3K |
|
3829
Safe Bulkers
SB
$781M
| $16.6K | ﹤0.01% |
11,371
+8,692
| +324% | +$14.4K |
|
3830
Syndax Pharmaceuticals
SNDX
$1.7B
| $16.6K | ﹤0.01% |
3,162
+2,798
| +769% | +$16K |
|
3831
Nature's Sunshine
NATR
$269M
| $16.6K | ﹤0.01% |
1,785
+1,329
| +291% | +$11.3K |
|
|
YARW
3832
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $16.5K | ﹤0.01% |
+1
| New | +$24K |
|
|
CWBR
3833
DELISTED
CohBar, Inc. Common Stock
CWBR
| $16.5K | ﹤0.01% |
169
+157
| +1,308% | +$15.8K |
|
3834
Maui Land & Pineapple Co
MLP
$310M
| $16.4K | ﹤0.01% |
1,437
+1,435
| +71,750% | +$16.1K |
|
3835
Equinor
EQNR
$96.3B
| $16.4K | ﹤0.01% |
747
-20
| -3% | -$450 |
|
|
CRR
3836
DELISTED
Carbo Ceramics Inc.
CRR
| $16.4K | ﹤0.01% |
4,679
+2,043
| +78% | +$8.57K |
|
|
TTPH
3837
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $16.2K | ﹤0.01% |
603
+461
| +325% | +$11.7K |
|
|
SREV
3838
DELISTED
ServiceSource International, Inc.
SREV
| $16K | ﹤0.01% |
17,388
+16,060
| +1,209% | +$16.8K |
|
|
MTEM
3839
DELISTED
Molecular Templates, Inc.
MTEM
| $15.9K | ﹤0.01% |
182
+144
| +379% | +$10.6K |
|
3840
ADMA Biologics
ADMA
$2.11B
| $15.6K | ﹤0.01% |
+4,115
| New | +$14.5K |
|
3841
Genco Shipping & Trading
GNK
$1.13B
| $15.4K | ﹤0.01% |
2,070
+1,289
| +165% | +$10.5K |
|
3842
Viridian Therapeutics
VRDN
$2.49B
| $15.4K | ﹤0.01% |
368
+338
| +1,127% | +$15.3K |
|
3843
FreightCar America
RAIL
$243M
| $15.4K | ﹤0.01% |
2,495
+1,899
| +319% | +$14K |
|
|
MGI
3844
DELISTED
MoneyGram International, Inc. New
MGI
| $15.3K | ﹤0.01% |
7,504
+2,714
| +57% | +$6.2K |
|
3845
Vuzix
VUZI
$220M
| $15.2K | ﹤0.01% |
+4,982
| New | +$20K |
|
|
BAS
3846
DELISTED
Basis Energy Services, Inc.
BAS
| $15.2K | ﹤0.01% |
3,991
+2,518
| +171% | +$12.3K |
|
3847
Franco-Nevada
FNV
$44.7B
| $15K | ﹤0.01% |
200
| – | – |
|
|
AMRS
3848
DELISTED
Amyris Inc.
AMRS
| $14.9K | ﹤0.01% |
7,147
+6,822
| +2,099% | +$26.9K |
|
|
RTW
3849
DELISTED
RTW Retailwinds, Inc.
RTW
| $14.9K | ﹤0.01% |
6,219
+4,884
| +366% | +$14.3K |
|
3850
Civeo
CVEO
$344M
| $14.9K | ﹤0.01% |
592
+19
| +3% | +$516 |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.